Pulse Biosciences, Inc. PLSE Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31K— | —— | -$193K— | —— | $0— | ||
| $6.59M-14.7% | $7.33M-23.6% | $8.78M+47.5% | $8.19M— | $7.73M— | ||
| -$18.58M-10.6% | -$17.43M+10.1% | -$19.39M-52.9% | -$19.17M-68.4% | -$16.8M-65.7% | ||
| -$18.9M-6.4% | -$17.99M+9.9% | -$20.1M-50.1% | -$20.01M-74.6% | -$17.76M-72.2% | ||
| -$19.15M-6.1% | -$18.25M+9.9% | -$20.37M-49.2% | -$20.28M-72.9% | -$18.04M-70.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pulse Biosciences, Inc.'s revenue?
- Pulse Biosciences, Inc. (PLSE) generated $751.0K in revenue over the trailing twelve months.
- Is Pulse Biosciences, Inc. profitable?
- Pulse Biosciences, Inc. is not currently profitable: it reported a net loss of $74.6M over the trailing twelve months, a -9929.0% net margin.
- What are Pulse Biosciences, Inc.'s profit margins?
- Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.
- Where does Pulse Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
